טוען...
Cognitive effects of hormone therapy continuation or discontinuation in a sample of women at risk for Alzheimer’s disease
Use of estrogen-based hormone therapy (HT), as a protection from cognitive decline and Alzheimer’s disease, is controversial although cumulative data supports HT use when initiated close to menopause onset with estrogen formulations containing 17β-estradiol (17β-E) being preferable to conjugated equ...
שמור ב:
| הוצא לאור ב: | Am J Geriatr Psychiatry |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654994/ https://ncbi.nlm.nih.gov/pubmed/26209223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2015.05.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|